Home › Funds › SOUTHEASTERN ASSET MANAGEMENT INC/TN/ › REGN
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ position in REGN
REGENERON PHARMACEUTICALS · Health Care
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ reported holding 152,322 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$95.0M, representing 4.95% of its reported portfolio and ranking #6 among its reported holdings. SOUTHEASTERN ASSET MANAGEMENT INC/TN/ has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SOUTHEASTERN ASSET MANAGEMENT INC/TN/'s REGN position evolved
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ first disclosed a stake in REGN in Q1 2025 at 114,880 shares (US$72.9M). The position peaked in Q4 2025 at 165,792 shares, worth US$128.0M. Across 6 filings, SOUTHEASTERN ASSET MANAGEMENT INC/TN/ increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 152,322 shares valued at US$95.0M — an increase of 21,660 shares quarter over quarter.. Notable position changes include a 40% increase in Q2 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 114.88K | $72.86M | New |
| Q2 2025 | 160.58K | $84.31M | Add |
| Q3 2025 | 144.61K | $81.31M | Reduce |
| Q4 2025 | 165.79K | $127.97M | Add |
| Q1 2026 | 130.66K | $100.95M | Reduce |
| Q2 2026 | 152.32K | $94.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- LOOMIS SAYLES & CO L P 1.86M sh · $1.16B · Q2 2026
More on SOUTHEASTERN ASSET MANAGEMENT INC/TN/
FAQ
How long has SOUTHEASTERN ASSET MANAGEMENT INC/TN/ held REGN?
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is SOUTHEASTERN ASSET MANAGEMENT INC/TN/'s current position in REGN?
As of Q2 2026, SOUTHEASTERN ASSET MANAGEMENT INC/TN/ holds 152.32K shares of REGN (REGENERON PHARMACEUTICALS), valued at $94.98M, representing 4.95% of its reported portfolio and ranking #6.
Has SOUTHEASTERN ASSET MANAGEMENT INC/TN/ been buying or selling REGN?
In the latest 13F filing (Q2 2026), SOUTHEASTERN ASSET MANAGEMENT INC/TN/ increased its position in REGN. The position peaked in Q4 2025 at 165.79K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.